SCHEMBL14099381

SCHEMBL14099381

Cc1ccc(N(c2ccc(C)cc2)c2ccc(N(c3ccc(C)cc3)c3ccc(C)cc3)c3nc4c5ccccc5c5ccccc5c4nc23)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
CRHR1 P34998 1/20 0.34
KDM1A O60341 2/20 0.33
TSHR P16473 1/20 0.33
CYP2C19 P33261 1/20 0.33
ADORA2A P29274 2/20 0.33
ADORA3 P0DMS8 1/20 0.33
ADORA1 P30542 1/20 0.33
KMT2A Q03164 3/20 0.33
NPC1 O15118 2/20 0.33
RAB9A P51151 2/20 0.33
MEN1 O00255 2/20 0.33
POLB P06746 2/20 0.33
XBP1 P17861 1/20 0.33
HTT P42858 1/20 0.33
ATM Q13315 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
LMNA P02545 1/20 0.33
MAPT P10636 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14099384 0.85 ALDH1A1 (0.38) ALDH1A1L3MBTL1TSHRCYP2C19KMT2A
SCHEMBL14492024 0.83 MAPT (0.34) ALDH1A1L3MBTL1CRHR1KDM1ATSHR
SCHEMBL14099380 0.82 TDP1 (0.43) ALDH1A1L3MBTL1KDM1ATSHRCYP2C19
SCHEMBL14099369 0.82 SIGMAR1 (0.38) ALDH1A1L3MBTL1TSHRCYP2C19ADORA2A
SCHEMBL14492022 0.81 MAPT (0.33) ALDH1A1L3MBTL1CRHR1KDM1ATSHR
SCHEMBL14492025 0.81 MAPT (0.33) ALDH1A1L3MBTL1CRHR1KDM1ATSHR
SCHEMBL14492007 0.81 SLC6A2 (0.37) ALDH1A1L3MBTL1KMT2AMEN1POLB
SCHEMBL2537763 0.79 ALDH1A1 (0.42) ALDH1A1L3MBTL1TSHRCYP2C19KMT2A
SCHEMBL14099421 0.78 KDM4E (0.35) ALDH1A1L3MBTL1CYP2C19HTTNPSR1
SCHEMBL14099514 0.78 KDM4E (0.35) ALDH1A1L3MBTL1CYP2C19HTTNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1956011-A1 AMINE COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT EMPLOYING THE SAME Idemitsu Kosan Co., Ltd. (JP) 2008-08-13 EP disclosed
US-20070132372-A1 AMINE BASED COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2007-06-14 US disclosed
US-20070132372-A1 AMINE BASED COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2007-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070132372-A1 AMINE BASED COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME KCNH2, SLC7A5, KCNH3 ALDH1A1 1210/4885L3MBTL1 2004/4885CRHR1 4725/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.